AC Immune SA
ACIU- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001651625
No open-market purchases or sales by AC Immune SA insiders were filed in the last 90 days; 43 institutions reported holding it in 13F filings for Q2 2026, worth $58.2M in total; no superinvestor holds it.
Q3 2023 vs. Q2 2023
How the institutions holding AC Immune SA changed between Q2 2023 and Q3 2023.
All holders in Q3 2023All holders in Q2 2023
| Measure | Q2 2023 | Q3 2023 | Change |
|---|---|---|---|
| Holders | 31 | 28 | −3 |
| Shares | 16.0M | 16.0M | −52.1K (−0.3%) |
| Value | $47.4M | $45.5M | −$1.83M (−3.9%) |
New holders (3)
Institutions that held AC Immune SA at the end of Q3 2023 but not at the end of Q2 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Citadel Advisors LLC | 1,097 | $3.13K | 0.00% |
| Simplex Trading, LLC | 553 | $1.00K | 0.00% |
| Qube Research & Technologies Ltd | 186 | $530 | 0.00% |
Sold out (6)
Institutions that held AC Immune SA at the end of Q2 2023 and filed for Q3 2023 without it.
| Institution | Shares, Q2 2023 | Value, Q2 2023 |
|---|---|---|
| State Street Corp | 56,369 | $166.6K |
| Millennium Management LLC | 51,532 | $152.3K |
| Two Sigma Investments, LP | 15,279 | $45.1K |
| Squarepoint Ops LLC | 11,036 | $32.6K |
| FNY Investment Advisers, LLC | 2,625 | $7.00K |
| Glassman Wealth Services | 26 | $77 |